Real-World Safety Analysis of Preschool Tree Nut Oral Immunotherapy

2008 Fleischer, 2005, The natural history of tree nut allergy, J Allergy Clin Immunol, 116, 1087, 10.1016/j.jaci.2005.09.002 Elizur, 2020, Clinical and molecular characterization of walnut and pecan allergy (Nut Cracker Study), J Allergy Clin Immunol Pract, 8, 157, 10.1016/j.jaip.2019.08.038 Sicherer, 2010, US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up, J Allergy Clin Immunol, 125, 1322, 10.1016/j.jaci.2010.03.029 Sicherer, 2003, Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: a 5-year follow-up study, J Allergy Clin Immunol, 112, 1203, 10.1016/S0091-6749(03)02026-8 McWilliam, 2015, The prevalence of tree nut allergy: a systematic review, Curr Allergy Asthma Rep, 15, 54, 10.1007/s11882-015-0555-8 Ducharme, 2022, Tree nut-induced anaphylaxis in Canadian Emergency Departments: rate, clinical characteristics and management, Ann Allergy Asthma Immunol, 129, 335, 10.1016/j.anai.2022.06.008 Abrams, 2021, Dietary exposures and allergy prevention in high-risk infants, Paediatr Child Health, 26, 504, 10.1093/pch/pxab064 Ewan, 2001, Long-term prospective observational study of patients with peanut and nut allergy after participation in a management plan, Lancet, 357, 111, 10.1016/S0140-6736(00)03543-1 Bock, 2007, Further fatalities caused by anaphylactic reactions to food, 2001-2006, J Allergy Clin Immunol, 119, 1016, 10.1016/j.jaci.2006.12.622 Nut, 2021, 1 Soller, 2019, First real-world safety analysis of preschool peanut oral immunotherapy, J Allergy Clin Immunol Pract, 7, 2759, 10.1016/j.jaip.2019.04.010 Soller, 2021, First real-world effectiveness analysis of preschool peanut oral immunotherapy, J Allergy Clin Immunol Pract, 9, 1349, 10.1016/j.jaip.2020.10.045 Moraly, 2020, Oral immunotherapy for hazelnut allergy: a single-center retrospective study on 100 patients, J Allergy Clin Immunol Pract, 8, 704, 10.1016/j.jaip.2019.10.045 Sabouraud, 2022, Real-life experience with hazelnut oral immunotherapy, Ann Allergy Asthma Immunol, 128, 432, 10.1016/j.anai.2022.01.002 Elizur, 2022, Cashew oral immunotherapy for desensitizing cashew-pistachio allergy (Nut Cracker Study), Allergy, 77, 1863, 10.1111/all.15212 Elizur, 2019, Walnut oral immunotherapy for desensitisation of walnut and additional tree nut allergies (Nut Cracker): a single-centre, prospective cohort study, Lancet Child Adolesc Health, 3, 312, 10.1016/S2352-4642(19)30029-X Andorf, 2018, Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial, Lancet Gastroenterol Hepatol, 3, 85, 10.1016/S2468-1253(17)30392-8 Andorf, 2019, A phase 2 randomized controlled multisite study using omalizumab-facilitated rapid desensitization to test continued vs discontinued dosing in multifood allergic individuals, EClinicalMedicine, 7, 27, 10.1016/j.eclinm.2018.12.006 Wasserman, 2021, Exploiting nut cross-reactivity to facilitate real-world treatment of tree nut allergy, Ann Allergy Asthma Immunol, 127, 149, 10.1016/j.anai.2021.04.010 Abrams, 2017, Oral food challenge outcomes in a pediatric tertiary care center, Allergy Asthma Clin Immunol, 13, 1, 10.1186/s13223-017-0215-8 Clark, 2007, Cashew nut causes more severe reactions than peanut: case-matched comparison in 141 children, Allergy, 62, 913, 10.1111/j.1398-9995.2007.01447.x Divaret-Chauveau, 2018, Threshold dose distribution for cashew nut allergy in children, Clin Exp Allergy, 48, 902, 10.1111/cea.13150 Röntynen, 2022, Optimizing tools for evaluating challenge outcomes in children with cashew nut allergy, Ann Allergy Asthma Immunol, 128, 270, 10.1016/j.anai.2021.12.006 Davoren, 2005, Cashew nut allergy is associated with a high risk of anaphylaxis, Arch Dis Child, 90, 1084, 10.1136/adc.2005.073817 Cox, 2010, Speaking the same language: the World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System, J Allergy Clin Immunol, 125, 569, 10.1016/j.jaci.2009.10.060 Vickery, 2017, Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective, J Allergy Clin Immunol, 139, 173, 10.1016/j.jaci.2016.05.027 Burks, 2012, Oral immunotherapy for treatment of egg allergy in children, N Engl J Med, 367, 233, 10.1056/NEJMoa1200435 Koren, 2023, Characteristics of patients diagnosed as non-allergic following food allergy oral immunotherapy referral, Pediatr Res, 93, 643, 10.1038/s41390-022-02119-3 Goldberg, 2020, Risk factors and treatment outcomes for oral immunotherapy–induced gastrointestinal symptoms and eosinophilic responses (OITIGER), J Allergy Clin Immunol Pract, 8, 125, 10.1016/j.jaip.2019.07.034 Goldberg, 2017, Oral immunotherapy–induced gastrointestinal symptoms and peripheral blood eosinophil responses, J Allergy Clin Immunol, 139, 1388, 10.1016/j.jaci.2016.09.053 Jones, 2022, Efficacy and safety of oral immunotherapy in children aged 1–3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study, Lancet, 399, 359, 10.1016/S0140-6736(21)02390-4 Santos, 2014, Basophil activation test discriminates between allergy and tolerance in peanut-sensitized children, J Allergy Clin Immunol, 134, 645, 10.1016/j.jaci.2014.04.039